nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Zoledronate—osteoporosis	0.15	0.2	CbGbCtD
Atazanavir—SLCO1B3—Conjugated Estrogens—osteoporosis	0.121	0.161	CbGbCtD
Atazanavir—SLCO1B3—Estradiol—osteoporosis	0.106	0.141	CbGbCtD
Atazanavir—ABCC1—Conjugated Estrogens—osteoporosis	0.0835	0.111	CbGbCtD
Atazanavir—CYP2C9—Estropipate—osteoporosis	0.0439	0.0584	CbGbCtD
Atazanavir—ABCB1—Ethinyl Estradiol—osteoporosis	0.0275	0.0365	CbGbCtD
Atazanavir—CYP3A4—Estropipate—osteoporosis	0.0255	0.034	CbGbCtD
Atazanavir—CYP3A4—Calcitriol—osteoporosis	0.0255	0.034	CbGbCtD
Atazanavir—CYP2C9—Cholecalciferol—osteoporosis	0.0226	0.0301	CbGbCtD
Atazanavir—CYP3A4—Ergocalciferol—osteoporosis	0.0204	0.0272	CbGbCtD
Atazanavir—ABCB1—Conjugated Estrogens—osteoporosis	0.0202	0.0268	CbGbCtD
Atazanavir—CYP2C9—Estradiol—osteoporosis	0.0182	0.0243	CbGbCtD
Atazanavir—ABCB1—Estradiol—osteoporosis	0.0177	0.0235	CbGbCtD
Atazanavir—CYP3A4—Raloxifene—osteoporosis	0.017	0.0227	CbGbCtD
Atazanavir—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0164	0.0219	CbGbCtD
Atazanavir—CYP3A4—Cholecalciferol—osteoporosis	0.0131	0.0175	CbGbCtD
Atazanavir—CYP3A4—Conjugated Estrogens—osteoporosis	0.0121	0.0161	CbGbCtD
Atazanavir—CYP3A4—Estradiol—osteoporosis	0.0106	0.0141	CbGbCtD
Atazanavir—Chest pain—Zoledronate—osteoporosis	0.00018	0.000725	CcSEcCtD
Atazanavir—Arthralgia—Zoledronate—osteoporosis	0.00018	0.000725	CcSEcCtD
Atazanavir—Myalgia—Zoledronate—osteoporosis	0.00018	0.000725	CcSEcCtD
Atazanavir—Palpitations—Conjugated Estrogens—osteoporosis	0.00018	0.000725	CcSEcCtD
Atazanavir—Insomnia—Risedronate—osteoporosis	0.00018	0.000724	CcSEcCtD
Atazanavir—Anxiety—Zoledronate—osteoporosis	0.00018	0.000723	CcSEcCtD
Atazanavir—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000179	0.000721	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000179	0.00072	CcSEcCtD
Atazanavir—Pruritus—Estropipate—osteoporosis	0.000178	0.000717	CcSEcCtD
Atazanavir—Discomfort—Zoledronate—osteoporosis	0.000178	0.000717	CcSEcCtD
Atazanavir—Asthenia—Alendronate—osteoporosis	0.000178	0.000716	CcSEcCtD
Atazanavir—Hypersensitivity—Ibandronate—osteoporosis	0.000178	0.000716	CcSEcCtD
Atazanavir—Cough—Conjugated Estrogens—osteoporosis	0.000178	0.000716	CcSEcCtD
Atazanavir—Dyspnoea—Risedronate—osteoporosis	0.000177	0.000714	CcSEcCtD
Atazanavir—Erythema multiforme—Estradiol—osteoporosis	0.000177	0.000713	CcSEcCtD
Atazanavir—Convulsion—Conjugated Estrogens—osteoporosis	0.000177	0.000711	CcSEcCtD
Atazanavir—Dry mouth—Zoledronate—osteoporosis	0.000176	0.000709	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000176	0.000709	CcSEcCtD
Atazanavir—Fatigue—Ethinyl Estradiol—osteoporosis	0.000176	0.000708	CcSEcCtD
Atazanavir—Pruritus—Alendronate—osteoporosis	0.000176	0.000706	CcSEcCtD
Atazanavir—Dyspepsia—Risedronate—osteoporosis	0.000175	0.000705	CcSEcCtD
Atazanavir—Eye disorder—Estradiol—osteoporosis	0.000175	0.000705	CcSEcCtD
Atazanavir—Tinnitus—Estradiol—osteoporosis	0.000175	0.000703	CcSEcCtD
Atazanavir—Constipation—Ethinyl Estradiol—osteoporosis	0.000175	0.000702	CcSEcCtD
Atazanavir—Confusional state—Zoledronate—osteoporosis	0.000174	0.000701	CcSEcCtD
Atazanavir—Hypersensitivity—Calcitriol—osteoporosis	0.000174	0.000701	CcSEcCtD
Atazanavir—Cardiac disorder—Estradiol—osteoporosis	0.000174	0.0007	CcSEcCtD
Atazanavir—Myalgia—Conjugated Estrogens—osteoporosis	0.000174	0.000698	CcSEcCtD
Atazanavir—Chest pain—Conjugated Estrogens—osteoporosis	0.000174	0.000698	CcSEcCtD
Atazanavir—Arthralgia—Conjugated Estrogens—osteoporosis	0.000174	0.000698	CcSEcCtD
Atazanavir—Asthenia—Ibandronate—osteoporosis	0.000173	0.000697	CcSEcCtD
Atazanavir—Anxiety—Conjugated Estrogens—osteoporosis	0.000173	0.000696	CcSEcCtD
Atazanavir—Nausea—Etidronic acid—osteoporosis	0.000173	0.000696	CcSEcCtD
Atazanavir—Oedema—Zoledronate—osteoporosis	0.000173	0.000695	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000172	0.000694	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000172	0.000694	CcSEcCtD
Atazanavir—Diarrhoea—Estropipate—osteoporosis	0.000172	0.000693	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Risedronate—osteoporosis	0.000172	0.000691	CcSEcCtD
Atazanavir—Infection—Zoledronate—osteoporosis	0.000172	0.000691	CcSEcCtD
Atazanavir—Fatigue—Risedronate—osteoporosis	0.000172	0.00069	CcSEcCtD
Atazanavir—Insomnia—Pamidronate—osteoporosis	0.000171	0.000689	CcSEcCtD
Atazanavir—Pruritus—Ibandronate—osteoporosis	0.000171	0.000687	CcSEcCtD
Atazanavir—Pain—Risedronate—osteoporosis	0.00017	0.000685	CcSEcCtD
Atazanavir—Constipation—Risedronate—osteoporosis	0.00017	0.000685	CcSEcCtD
Atazanavir—Angiopathy—Estradiol—osteoporosis	0.00017	0.000684	CcSEcCtD
Atazanavir—Shock—Zoledronate—osteoporosis	0.00017	0.000684	CcSEcCtD
Atazanavir—Diarrhoea—Alendronate—osteoporosis	0.00017	0.000683	CcSEcCtD
Atazanavir—Asthenia—Calcitriol—osteoporosis	0.00017	0.000682	CcSEcCtD
Atazanavir—Nervous system disorder—Zoledronate—osteoporosis	0.00017	0.000682	CcSEcCtD
Atazanavir—Immune system disorder—Estradiol—osteoporosis	0.000169	0.000681	CcSEcCtD
Atazanavir—Mediastinal disorder—Estradiol—osteoporosis	0.000169	0.00068	CcSEcCtD
Atazanavir—Dyspnoea—Pamidronate—osteoporosis	0.000169	0.000679	CcSEcCtD
Atazanavir—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000168	0.000677	CcSEcCtD
Atazanavir—Somnolence—Pamidronate—osteoporosis	0.000168	0.000677	CcSEcCtD
Atazanavir—Skin disorder—Zoledronate—osteoporosis	0.000168	0.000675	CcSEcCtD
Atazanavir—Pruritus—Calcitriol—osteoporosis	0.000167	0.000673	CcSEcCtD
Atazanavir—Hyperhidrosis—Zoledronate—osteoporosis	0.000167	0.000672	CcSEcCtD
Atazanavir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000167	0.000672	CcSEcCtD
Atazanavir—Diarrhoea—Raloxifene—osteoporosis	0.000167	0.000672	CcSEcCtD
Atazanavir—Dyspepsia—Pamidronate—osteoporosis	0.000167	0.00067	CcSEcCtD
Atazanavir—Dizziness—Estropipate—osteoporosis	0.000167	0.00067	CcSEcCtD
Atazanavir—Oedema—Conjugated Estrogens—osteoporosis	0.000166	0.00067	CcSEcCtD
Atazanavir—Alopecia—Estradiol—osteoporosis	0.000166	0.000667	CcSEcCtD
Atazanavir—Infection—Conjugated Estrogens—osteoporosis	0.000165	0.000665	CcSEcCtD
Atazanavir—Diarrhoea—Ibandronate—osteoporosis	0.000165	0.000665	CcSEcCtD
Atazanavir—Anorexia—Zoledronate—osteoporosis	0.000165	0.000663	CcSEcCtD
Atazanavir—Decreased appetite—Pamidronate—osteoporosis	0.000164	0.000662	CcSEcCtD
Atazanavir—Mental disorder—Estradiol—osteoporosis	0.000164	0.000661	CcSEcCtD
Atazanavir—Dizziness—Alendronate—osteoporosis	0.000164	0.00066	CcSEcCtD
Atazanavir—Shock—Conjugated Estrogens—osteoporosis	0.000164	0.000659	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000163	0.000657	CcSEcCtD
Atazanavir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000163	0.000657	CcSEcCtD
Atazanavir—Malnutrition—Estradiol—osteoporosis	0.000163	0.000657	CcSEcCtD
Atazanavir—Fatigue—Pamidronate—osteoporosis	0.000163	0.000656	CcSEcCtD
Atazanavir—Gastrointestinal pain—Risedronate—osteoporosis	0.000163	0.000655	CcSEcCtD
Atazanavir—Urticaria—Ethinyl Estradiol—osteoporosis	0.000162	0.000653	CcSEcCtD
Atazanavir—Pain—Pamidronate—osteoporosis	0.000162	0.000651	CcSEcCtD
Atazanavir—Constipation—Pamidronate—osteoporosis	0.000162	0.000651	CcSEcCtD
Atazanavir—Diarrhoea—Calcitriol—osteoporosis	0.000162	0.000651	CcSEcCtD
Atazanavir—Skin disorder—Conjugated Estrogens—osteoporosis	0.000162	0.00065	CcSEcCtD
Atazanavir—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000161	0.000649	CcSEcCtD
Atazanavir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000161	0.000649	CcSEcCtD
Atazanavir—Dizziness—Raloxifene—osteoporosis	0.000161	0.000649	CcSEcCtD
Atazanavir—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000161	0.000647	CcSEcCtD
Atazanavir—Flatulence—Estradiol—osteoporosis	0.000161	0.000647	CcSEcCtD
Atazanavir—Tension—Estradiol—osteoporosis	0.00016	0.000644	CcSEcCtD
Atazanavir—Vomiting—Estropipate—osteoporosis	0.00016	0.000644	CcSEcCtD
Atazanavir—Dysgeusia—Estradiol—osteoporosis	0.00016	0.000643	CcSEcCtD
Atazanavir—Dizziness—Ibandronate—osteoporosis	0.00016	0.000643	CcSEcCtD
Atazanavir—Rash—Estropipate—osteoporosis	0.000159	0.000639	CcSEcCtD
Atazanavir—Dermatitis—Estropipate—osteoporosis	0.000159	0.000638	CcSEcCtD
Atazanavir—Anorexia—Conjugated Estrogens—osteoporosis	0.000159	0.000638	CcSEcCtD
Atazanavir—Nervousness—Estradiol—osteoporosis	0.000159	0.000638	CcSEcCtD
Atazanavir—Urticaria—Risedronate—osteoporosis	0.000158	0.000636	CcSEcCtD
Atazanavir—Back pain—Estradiol—osteoporosis	0.000158	0.000635	CcSEcCtD
Atazanavir—Headache—Estropipate—osteoporosis	0.000158	0.000635	CcSEcCtD
Atazanavir—Vomiting—Alendronate—osteoporosis	0.000158	0.000635	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000157	0.000634	CcSEcCtD
Atazanavir—Abdominal pain—Risedronate—osteoporosis	0.000157	0.000633	CcSEcCtD
Atazanavir—Body temperature increased—Risedronate—osteoporosis	0.000157	0.000633	CcSEcCtD
Atazanavir—Rash—Alendronate—osteoporosis	0.000156	0.000629	CcSEcCtD
Atazanavir—Insomnia—Zoledronate—osteoporosis	0.000156	0.000629	CcSEcCtD
Atazanavir—Dermatitis—Alendronate—osteoporosis	0.000156	0.000629	CcSEcCtD
Atazanavir—Feeling abnormal—Pamidronate—osteoporosis	0.000156	0.000627	CcSEcCtD
Atazanavir—Headache—Alendronate—osteoporosis	0.000155	0.000625	CcSEcCtD
Atazanavir—Vomiting—Raloxifene—osteoporosis	0.000155	0.000624	CcSEcCtD
Atazanavir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000155	0.000623	CcSEcCtD
Atazanavir—Dyspnoea—Zoledronate—osteoporosis	0.000154	0.00062	CcSEcCtD
Atazanavir—Rash—Raloxifene—osteoporosis	0.000154	0.000619	CcSEcCtD
Atazanavir—Dermatitis—Raloxifene—osteoporosis	0.000154	0.000618	CcSEcCtD
Atazanavir—Somnolence—Zoledronate—osteoporosis	0.000154	0.000618	CcSEcCtD
Atazanavir—Vomiting—Ibandronate—osteoporosis	0.000154	0.000618	CcSEcCtD
Atazanavir—Headache—Raloxifene—osteoporosis	0.000153	0.000615	CcSEcCtD
Atazanavir—Rash—Ibandronate—osteoporosis	0.000152	0.000613	CcSEcCtD
Atazanavir—Dermatitis—Ibandronate—osteoporosis	0.000152	0.000612	CcSEcCtD
Atazanavir—Dyspepsia—Zoledronate—osteoporosis	0.000152	0.000612	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000152	0.00061	CcSEcCtD
Atazanavir—Ill-defined disorder—Estradiol—osteoporosis	0.000151	0.000609	CcSEcCtD
Atazanavir—Headache—Ibandronate—osteoporosis	0.000151	0.000609	CcSEcCtD
Atazanavir—Insomnia—Conjugated Estrogens—osteoporosis	0.000151	0.000606	CcSEcCtD
Atazanavir—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00015	0.000605	CcSEcCtD
Atazanavir—Vomiting—Calcitriol—osteoporosis	0.00015	0.000605	CcSEcCtD
Atazanavir—Decreased appetite—Zoledronate—osteoporosis	0.00015	0.000604	CcSEcCtD
Atazanavir—Agitation—Estradiol—osteoporosis	0.00015	0.000603	CcSEcCtD
Atazanavir—Nausea—Estropipate—osteoporosis	0.00015	0.000602	CcSEcCtD
Atazanavir—Abdominal pain—Pamidronate—osteoporosis	0.00015	0.000602	CcSEcCtD
Atazanavir—Body temperature increased—Pamidronate—osteoporosis	0.00015	0.000602	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000149	0.0006	CcSEcCtD
Atazanavir—Angioedema—Estradiol—osteoporosis	0.000149	0.0006	CcSEcCtD
Atazanavir—Rash—Calcitriol—osteoporosis	0.000149	0.0006	CcSEcCtD
Atazanavir—Fatigue—Zoledronate—osteoporosis	0.000149	0.0006	CcSEcCtD
Atazanavir—Dermatitis—Calcitriol—osteoporosis	0.000149	0.000599	CcSEcCtD
Atazanavir—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000148	0.000597	CcSEcCtD
Atazanavir—Headache—Calcitriol—osteoporosis	0.000148	0.000596	CcSEcCtD
Atazanavir—Somnolence—Conjugated Estrogens—osteoporosis	0.000148	0.000595	CcSEcCtD
Atazanavir—Pain—Zoledronate—osteoporosis	0.000148	0.000595	CcSEcCtD
Atazanavir—Constipation—Zoledronate—osteoporosis	0.000148	0.000595	CcSEcCtD
Atazanavir—Nausea—Alendronate—osteoporosis	0.000147	0.000593	CcSEcCtD
Atazanavir—Malaise—Estradiol—osteoporosis	0.000147	0.000592	CcSEcCtD
Atazanavir—Hypersensitivity—Risedronate—osteoporosis	0.000147	0.00059	CcSEcCtD
Atazanavir—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000147	0.000589	CcSEcCtD
Atazanavir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000146	0.000589	CcSEcCtD
Atazanavir—Syncope—Estradiol—osteoporosis	0.000146	0.000589	CcSEcCtD
Atazanavir—Nausea—Raloxifene—osteoporosis	0.000145	0.000583	CcSEcCtD
Atazanavir—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000145	0.000582	CcSEcCtD
Atazanavir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000144	0.000581	CcSEcCtD
Atazanavir—Palpitations—Estradiol—osteoporosis	0.000144	0.00058	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000144	0.000578	CcSEcCtD
Atazanavir—Fatigue—Conjugated Estrogens—osteoporosis	0.000143	0.000577	CcSEcCtD
Atazanavir—Nausea—Ibandronate—osteoporosis	0.000143	0.000577	CcSEcCtD
Atazanavir—Loss of consciousness—Estradiol—osteoporosis	0.000143	0.000577	CcSEcCtD
Atazanavir—Asthenia—Risedronate—osteoporosis	0.000143	0.000575	CcSEcCtD
Atazanavir—Feeling abnormal—Zoledronate—osteoporosis	0.000142	0.000573	CcSEcCtD
Atazanavir—Cough—Estradiol—osteoporosis	0.000142	0.000573	CcSEcCtD
Atazanavir—Pain—Conjugated Estrogens—osteoporosis	0.000142	0.000573	CcSEcCtD
Atazanavir—Constipation—Conjugated Estrogens—osteoporosis	0.000142	0.000573	CcSEcCtD
Atazanavir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000141	0.000569	CcSEcCtD
Atazanavir—Hypertension—Estradiol—osteoporosis	0.000141	0.000567	CcSEcCtD
Atazanavir—Pruritus—Risedronate—osteoporosis	0.000141	0.000567	CcSEcCtD
Atazanavir—Nausea—Calcitriol—osteoporosis	0.00014	0.000565	CcSEcCtD
Atazanavir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00014	0.000562	CcSEcCtD
Atazanavir—Hypersensitivity—Pamidronate—osteoporosis	0.000139	0.000561	CcSEcCtD
Atazanavir—Myalgia—Estradiol—osteoporosis	0.000139	0.000559	CcSEcCtD
Atazanavir—Arthralgia—Estradiol—osteoporosis	0.000139	0.000559	CcSEcCtD
Atazanavir—Chest pain—Estradiol—osteoporosis	0.000139	0.000559	CcSEcCtD
Atazanavir—Anxiety—Estradiol—osteoporosis	0.000138	0.000557	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000138	0.000555	CcSEcCtD
Atazanavir—Urticaria—Zoledronate—osteoporosis	0.000137	0.000552	CcSEcCtD
Atazanavir—Discomfort—Estradiol—osteoporosis	0.000137	0.000552	CcSEcCtD
Atazanavir—Abdominal pain—Zoledronate—osteoporosis	0.000137	0.00055	CcSEcCtD
Atazanavir—Body temperature increased—Zoledronate—osteoporosis	0.000137	0.00055	CcSEcCtD
Atazanavir—Diarrhoea—Risedronate—osteoporosis	0.000136	0.000548	CcSEcCtD
Atazanavir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000136	0.000548	CcSEcCtD
Atazanavir—Dry mouth—Estradiol—osteoporosis	0.000136	0.000547	CcSEcCtD
Atazanavir—Asthenia—Pamidronate—osteoporosis	0.000136	0.000546	CcSEcCtD
Atazanavir—Dizziness—Ethinyl Estradiol—osteoporosis	0.000135	0.000543	CcSEcCtD
Atazanavir—Confusional state—Estradiol—osteoporosis	0.000134	0.00054	CcSEcCtD
Atazanavir—Pruritus—Pamidronate—osteoporosis	0.000134	0.000539	CcSEcCtD
Atazanavir—Oedema—Estradiol—osteoporosis	0.000133	0.000536	CcSEcCtD
Atazanavir—Infection—Estradiol—osteoporosis	0.000132	0.000532	CcSEcCtD
Atazanavir—Urticaria—Conjugated Estrogens—osteoporosis	0.000132	0.000532	CcSEcCtD
Atazanavir—Dizziness—Risedronate—osteoporosis	0.000132	0.00053	CcSEcCtD
Atazanavir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000132	0.000529	CcSEcCtD
Atazanavir—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000132	0.000529	CcSEcCtD
Atazanavir—Shock—Estradiol—osteoporosis	0.000131	0.000527	CcSEcCtD
Atazanavir—Nervous system disorder—Estradiol—osteoporosis	0.000131	0.000526	CcSEcCtD
Atazanavir—Vomiting—Ethinyl Estradiol—osteoporosis	0.00013	0.000522	CcSEcCtD
Atazanavir—Diarrhoea—Pamidronate—osteoporosis	0.000129	0.000521	CcSEcCtD
Atazanavir—Skin disorder—Estradiol—osteoporosis	0.000129	0.000521	CcSEcCtD
Atazanavir—Hyperhidrosis—Estradiol—osteoporosis	0.000129	0.000518	CcSEcCtD
Atazanavir—Rash—Ethinyl Estradiol—osteoporosis	0.000129	0.000518	CcSEcCtD
Atazanavir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000129	0.000517	CcSEcCtD
Atazanavir—Headache—Ethinyl Estradiol—osteoporosis	0.000128	0.000515	CcSEcCtD
Atazanavir—Hypersensitivity—Zoledronate—osteoporosis	0.000127	0.000512	CcSEcCtD
Atazanavir—Vomiting—Risedronate—osteoporosis	0.000127	0.000509	CcSEcCtD
Atazanavir—Rash—Risedronate—osteoporosis	0.000126	0.000505	CcSEcCtD
Atazanavir—Dermatitis—Risedronate—osteoporosis	0.000125	0.000504	CcSEcCtD
Atazanavir—Dizziness—Pamidronate—osteoporosis	0.000125	0.000503	CcSEcCtD
Atazanavir—Headache—Risedronate—osteoporosis	0.000125	0.000502	CcSEcCtD
Atazanavir—Asthenia—Zoledronate—osteoporosis	0.000124	0.000499	CcSEcCtD
Atazanavir—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000123	0.000493	CcSEcCtD
Atazanavir—Pruritus—Zoledronate—osteoporosis	0.000122	0.000492	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000121	0.000488	CcSEcCtD
Atazanavir—Nausea—Ethinyl Estradiol—osteoporosis	0.000121	0.000488	CcSEcCtD
Atazanavir—Insomnia—Estradiol—osteoporosis	0.00012	0.000485	CcSEcCtD
Atazanavir—Vomiting—Pamidronate—osteoporosis	0.00012	0.000484	CcSEcCtD
Atazanavir—Asthenia—Conjugated Estrogens—osteoporosis	0.000119	0.00048	CcSEcCtD
Atazanavir—Rash—Pamidronate—osteoporosis	0.000119	0.00048	CcSEcCtD
Atazanavir—Dermatitis—Pamidronate—osteoporosis	0.000119	0.00048	CcSEcCtD
Atazanavir—Dyspnoea—Estradiol—osteoporosis	0.000119	0.000478	CcSEcCtD
Atazanavir—Headache—Pamidronate—osteoporosis	0.000119	0.000477	CcSEcCtD
Atazanavir—Somnolence—Estradiol—osteoporosis	0.000118	0.000476	CcSEcCtD
Atazanavir—Diarrhoea—Zoledronate—osteoporosis	0.000118	0.000476	CcSEcCtD
Atazanavir—Nausea—Risedronate—osteoporosis	0.000118	0.000476	CcSEcCtD
Atazanavir—Pruritus—Conjugated Estrogens—osteoporosis	0.000118	0.000474	CcSEcCtD
Atazanavir—Dyspepsia—Estradiol—osteoporosis	0.000117	0.000472	CcSEcCtD
Atazanavir—Decreased appetite—Estradiol—osteoporosis	0.000116	0.000466	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000115	0.000463	CcSEcCtD
Atazanavir—Fatigue—Estradiol—osteoporosis	0.000115	0.000462	CcSEcCtD
Atazanavir—Dizziness—Zoledronate—osteoporosis	0.000114	0.00046	CcSEcCtD
Atazanavir—Pain—Estradiol—osteoporosis	0.000114	0.000458	CcSEcCtD
Atazanavir—Constipation—Estradiol—osteoporosis	0.000114	0.000458	CcSEcCtD
Atazanavir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000114	0.000458	CcSEcCtD
Atazanavir—Nausea—Pamidronate—osteoporosis	0.000112	0.000452	CcSEcCtD
Atazanavir—Dizziness—Conjugated Estrogens—osteoporosis	0.00011	0.000443	CcSEcCtD
Atazanavir—Vomiting—Zoledronate—osteoporosis	0.00011	0.000442	CcSEcCtD
Atazanavir—Feeling abnormal—Estradiol—osteoporosis	0.00011	0.000442	CcSEcCtD
Atazanavir—Rash—Zoledronate—osteoporosis	0.000109	0.000438	CcSEcCtD
Atazanavir—Gastrointestinal pain—Estradiol—osteoporosis	0.000109	0.000438	CcSEcCtD
Atazanavir—Dermatitis—Zoledronate—osteoporosis	0.000109	0.000438	CcSEcCtD
Atazanavir—Headache—Zoledronate—osteoporosis	0.000108	0.000436	CcSEcCtD
Atazanavir—Vomiting—Conjugated Estrogens—osteoporosis	0.000106	0.000426	CcSEcCtD
Atazanavir—Urticaria—Estradiol—osteoporosis	0.000106	0.000426	CcSEcCtD
Atazanavir—Body temperature increased—Estradiol—osteoporosis	0.000105	0.000424	CcSEcCtD
Atazanavir—Abdominal pain—Estradiol—osteoporosis	0.000105	0.000424	CcSEcCtD
Atazanavir—Rash—Conjugated Estrogens—osteoporosis	0.000105	0.000422	CcSEcCtD
Atazanavir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000105	0.000422	CcSEcCtD
Atazanavir—Headache—Conjugated Estrogens—osteoporosis	0.000104	0.000419	CcSEcCtD
Atazanavir—Nausea—Zoledronate—osteoporosis	0.000103	0.000413	CcSEcCtD
Atazanavir—Nausea—Conjugated Estrogens—osteoporosis	9.89e-05	0.000398	CcSEcCtD
Atazanavir—Hypersensitivity—Estradiol—osteoporosis	9.81e-05	0.000395	CcSEcCtD
Atazanavir—Asthenia—Estradiol—osteoporosis	9.56e-05	0.000384	CcSEcCtD
Atazanavir—Pruritus—Estradiol—osteoporosis	9.42e-05	0.000379	CcSEcCtD
Atazanavir—Diarrhoea—Estradiol—osteoporosis	9.11e-05	0.000367	CcSEcCtD
Atazanavir—Dizziness—Estradiol—osteoporosis	8.81e-05	0.000354	CcSEcCtD
Atazanavir—Vomiting—Estradiol—osteoporosis	8.47e-05	0.000341	CcSEcCtD
Atazanavir—Rash—Estradiol—osteoporosis	8.4e-05	0.000338	CcSEcCtD
Atazanavir—Dermatitis—Estradiol—osteoporosis	8.39e-05	0.000338	CcSEcCtD
Atazanavir—Headache—Estradiol—osteoporosis	8.34e-05	0.000336	CcSEcCtD
Atazanavir—Nausea—Estradiol—osteoporosis	7.91e-05	0.000318	CcSEcCtD
